Skip to main content
PMC home page
Environmental Health logoLink to Environmental Health
. 2019 Oct 29;18:90. doi: 10.1186/s12940-019-0532-0

Does the oxidative stress play a role in the associations between outdoor air pollution and persistent asthma in adults? Findings from the EGEA study

Anaïs Havet 1,2,✉, Zhen Li 3, Farid Zerimech 4, Margaux Sanchez 5, Valérie Siroux 6, Nicole Le Moual 1,2, Bert Brunekreef 7,8, Nino Künzli 9,10, Bénédicte Jacquemin 1,2, Raphaëlle Varraso 1,2, Régis Matran 11,#, Rachel Nadif 1,2,#
PMCID: PMC6819357  PMID: 31665023

Abstract

Background

Evidences that oxidative stress plays a role in the associations between outdoor air pollution and asthma are growing. We aimed to study the role of plasma fluorescent oxidation products levels (FlOPs; an oxidative stress-related biomarker), as potential mediators, in the associations between outdoor air pollution and persistent asthma.

Methods

Analyses were conducted in 204 adult asthmatics followed up in the French case-control and family study on asthma (EGEA; the Epidemiological study of the Genetic and Environmental factors of Asthma). Persistent asthma was defined as having current asthma at EGEA2 (baseline, 2003–2007) and EGEA3 (follow-up, 2011–2013). Exposures to nitrogen dioxide, nitrogen oxides, road traffic, particulate matter with a diameter ≤ 10 μm (PM10) and ≤ 2.5 μm were estimated by ESCAPE models (2009–2010), and ozone (O3) by IFEN models (2004). We used a mediation analysis to assess the mediated effect by FlOPs levels and the interaction between FlOPs levels and air pollution.

Results

FlOPs levels increased with PM10 and O3 (adjusted β = 0.04 (95%CI 0.001–0.08), aβ = 0.04 (95%CI 0.009–0.07) per 10 μg/m3, respectively), and the risk of persistent asthma increased with FlOPs levels (aOR = 1.81 (95%CI 1.08–3.02)). The risk of persistent asthma decreased with exposures to NO2, NOx and PM2.5 (aOR ranging from 0.62 to 0.94), and increased with exposures to PM10, O3, O3-summer and road traffic, the greater effect being observed for O3 (aOR = 1.78, 95% CI 0.73–4.37, per 10 μg/m3). Using mediation analysis, we observed a positive total effect (aOR = 2.16, 95%CI 0.70–11.9), a positive direct effect of O3 on persistent asthma (OR = 1.68, 95%CI 0.57–7.25), and a positive indirect effect mediated by FIOPs levels (aOR = 1.28 (95%CI 1.01–2.29)) accounting for 41% of the total effect.

Conclusions

Our results add insights on the role of oxidative stress in the association between air pollution and persistent asthma.

Keywords: Epidemiology, Outdoor air pollution, Persistent asthma, Oxidative stress, Fluorescent oxidation products, Mediation analysis

Background

Evidences that outdoor air pollution is associated with asthma incidence, and various asthma phenotypes as asthma control or asthma severity among asthmatics keep going up [1, 2], but the associations between outdoor air pollution and persistent asthma are very scarcely studied in adults. To our knowledge, only one study has investigated the associations between nitrogen dioxide (NO2) exposure, traffic road and persistent asthma, and showed that living close to a major road was associated with persistent asthma in adults followed up over eight years [3].

The underlying biological mechanisms by which outdoor air pollution may affect respiratory health include inflammatory processes, immune response modulations, genetic modifications and oxidative stress damages, which are increasingly suggested. Asthma is an oxidative stress-related disease [4], and exposures to ozone (O3), NO2 and particulate matter (PM) have been found associated with oxidative stress [5]. Studying biomarkers is a useful approach to provide new insights into the biological mechanisms that drive the disease process, to predict the development and progression of a disease and to personalize intervention strategies [6, 7]. Among the various biological markers related to oxidative stress, plasma fluorescent oxidation products (FlOPs) levels are biomarkers of damages that reflect systemic oxidative stress [8] and are of growing interest in epidemiology. In prospective studies, high plasma FlOPs levels were positively associated with the incidence of coronary heart diseases (CHD) among men without previous cardiovascular events [9], and with the risk of future CHD in women [10]. Regarding asthma, among adults from the Epidemiological study of the Genetic and Environmental factors of Asthma (EGEA), we recently reported higher plasma FlOPs levels significantly associated with asthma attacks, poor asthma control and poor lung function [11]. Overall, better understanding the underlying biological mechanisms related to asthma, and discovering novel biomarkers is the first step towards improving asthma management. To our knowledge, only two studies have investigated the associations between environmental factors and FlOPs levels. Among a population of U.S. trucking industry employees, short-term exposure to occupational PM2.5 was unrelated to plasma FlOPs levels [12]. In the EGEA study, occupational exposure to irritant cleaning products and to low molecular weight agents, especially highly reactive chemicals, were significantly and positively associated with higher plasma FlOPs levels in men, and an association was suggested for irritant cleaning products in women [13]. To date, the role of plasma FlOPs levels in the association between outdoor air pollution and asthma has never been studied.

We hypothesized that oxidative stress is one of the underlying biological mechanisms involved in the association between outdoor air pollution and persistent asthma. Among adults followed up in the EGEA study, we first studied the associations between outdoor air pollution (NO2, nitrogen oxides (NOx), particulate matter (PM), traffic load, traffic intensity, O3 and O3-summer), plasma FlOPs levels and persistent asthma. Then, according to the results, we investigated the role of plasma FlOPs levels as potential mediators in the association between outdoor air pollution and persistent asthma. We performed a mediation analysis which quantified both the mediated effect by FlOPs levels and the interaction between FlOPs levels and outdoor air pollution.

Methods

Study design

The EGEA is a cohort study based on an initial group of asthma cases recruited in chest clinics from five French cities (1991–1995) along with their first-degree relatives, and a group of controls (https://egeanet.vjf.inserm.fr/). The protocol and descriptive characteristics have been described previously [14, 15], and inclusion criteria used to define asthmatic cases and controls were described in Additional file 1. A 12-year follow-up of the initial cohort was conducted between 2003 and 2007 (EGEA2) [16], and 1571 adults aged ≥16 years had a complete examination. As a follow-up study of EGEA2, the third survey (EGEA3, 2011–2013, n = 1558) was conducted using self-completed questionnaire only. The EGEA collection was certified ISO 9001 since 2006 to 2018 [17]. Ethical approval was obtained from the relevant institutional review board committees (Cochin Port-Royal Hospital and Necker-Enfants Malades Hospital, Paris). All participants signed a written informed consent.

The analyses included 204 adults with current asthma at EGEA2, followed up at EGEA3, and with data on outdoor air pollution and plasma FlOPs levels (Additional file 2: Figure S1). In comparison to participants not included in the analyses, participants included had lower body mass index, lived longer at the same residential address and had lower exposure to NO2, PM2.5, O3 and O3-summer (all P-value≤0. 05, Additional file 1: Table S1). No differences were found regarding other variables.

Definition of persistent asthma

At EGEA2, the participants with ever asthma answered positively to at least one of the two following questions: “Have you ever had attacks of breathlessness at rest with wheezing?” or “Have you ever had asthma attacks?”, or were recruited as asthmatic cases at EGEA1. Among participants with ever asthma, those with current asthma reported asthma attacks or the use of asthma medication in the past twelve months. Participants with persistent asthma had current asthma at both EGEA2 and EGEA3, and those with remittent asthma had current asthma only at EGEA2. Participants with remittent asthma were used as reference (see Additional file 1 and for further respiratory outcomes definitions).

Exposure assessment

Available air pollution data from ESCAPE (European Study of Cohorts for Air Pollution Effects) were NO2, NOx and particulate matter with a diameter ≤ 10 and ≤ 2.5 μm (PM10 and PM2.5), and those from IFEN (French Institute for the Environment) were O3 and O3-summer. Outdoor air pollution exposures were assigned to each participant’s residential address.

Annual air pollution levels of NO2 and particulate matter were derived from ESCAPE standardised models (www.escapeproject.eu). Briefly, the ESCAPE monitoring campaigns took place between 2009 and 2010, including 40 measurement sites for NO2 and NOx in Paris, Lyon, Grenoble and Marseille, and 20 particulate matter measurement sites in Paris and Grenoble. Land-use regression (LUR) models were developed and two indicators of road traffic exposure were also calculated. Traffic intensity on nearest road was defined as the number of motor vehicles circulating per day on the nearest road to the participant’s home and was expressed in vehicles per day. Total traffic load was defined as the traffic load on all major roads based around a buffer of 100 m from the participant’s home and was expressed by traffic intensity multiplied by road length. Back-extrapolation was used to transfer the current LUR models (2009–2010) to earlier years (2003–2007, EGEA2) (see Additional file 1 for more details). In our study, the estimation of outdoor air pollution by ESCAPE took place after EGEA2, and accordingly we also analysed the back-extrapolated pollution estimates in order to obtain a better temporality between outdoor air pollution and plasma collection. Back-extrapolated pollution data were available for NO2 and NOx in all cities, and for PM10 in Paris. The spatial resolution was 50 m × 50 m. In order to supplement the ESCAPE data set, we used O3 and O3-summer exposures from the IFEN (see Additional file 1 for more details). The O3 estimate was the yearly mean ozone level in 2004 for each participant at the residential address and derived from a geo-statistical model as described previously [18]. The O3-summer exposure was assessed from the monthly means from April to September. The spatial resolution was 4 km × 4 km.

Measurement of plasma FlOPs levels

Plasma samples were collected in EGEA2 between 2003 and 2006 and stored immediately at − 80 °C during 5.0 to 8.0 years until FlOPs measurements. Plasma FlOPs levels were measured as previously described [8, 13] (Additional file 1). Briefly, plasma was extracted into a mixture of ethanol/ether (3/1 v/v) and measured using a spectrofluorimeter (360 nm excitation wavelength, 430 nm emission wavelength). Fluorescence was expressed as a unit of relative fluorescence intensity (RFU/mL) of plasma.

Statistical methods

Due to their skewed distribution, plasma FlOPs levels were log10-transformed. Due to the familial dependence of the data, multivariate analyses (except mediation analyses) took into account dependence between observations. Linear regression models and logistic regression models with random effects on center and familial dependence were used to study the associations between outdoor air pollution with plasma FlOPs levels, and between outdoor air pollution and persistent asthma, respectively. To control a potential effect of short-term exposure to O3 in the associations between O3 with plasma FlOPs levels and persistent asthma, further adjustment for the season of plasma collection (EGEA2) was conducted. Logistic regression models using generalized estimated equations (GEEs) on familial dependence were performed to study associations between plasma FlOPs levels and persistent asthma. To study only the road traffic effect, estimates of associations between road traffic with persistent asthma or plasma FlOPs levels were also adjusted for background NO2. To obtain a better temporality between outdoor air pollution assessed by ESCAPE and plasma collection, analyses with back-extrapolated pollution estimates were also performed.

We used a direct acyclic graph to represent our mediation model (Fig. 1), and conducted mediation analysis based on a counterfactual approach by using the CAUSALMED procedure [19, 20] (see Additional file 1). Mediation analysis was performed for air pollutants associated with both persistent asthma and plasma FlOPs levels, regardless of the significance of the association between air pollutant and persistent asthma. Models did not include random effects on center and familial dependence. The four-way decomposition was used to investigate the proportions of total effect that were attributable to the controlled direct effect, to mediation (the pure indirect effect), to interaction (the reference interaction between pollutant and plasma FlOPs levels) and to both mediation and interaction (the mediated interaction) [21]. Percentages mediated and due to interaction were given. All these components were defined in Additional file 1.

Fig. 1.

Fig. 1

Open in a new tab

Direct acyclic graph of the proposed mediation model. FlOPs: fluorescent oxidation products

All estimates were adjusted for age (continuous), sex and smoking status (never-, ex- or current smokers). We defined never-smoker as a participant who have never smoked in their life, ex-smoker as a participant who quit smoking for at least 4 weeks at EGEA2 and current smoker as a participant who was smoking at least one cigarette a day for more than 1 year at EGEA2. The results are expressed for an increase of 20 μg/m3 of NOx, 10 μg/m3 of NO2, PM10, O3 and O3-summer and 5 μg/m3 of PM2.5. The results of traffic load are expressed for 4 million vehicles multiplied by meters per day on major roads within a 100 m buffer, and those of traffic intensity for an increase of 5000 vehicles per day on major roads. We performed sensitivity analyses by excluding participants who lived at the same address for < 1 year. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).

Results

At EGEA2, the mean age of the 204 adults was 39 years, 48% were men, 24% were current smoker, 79% had persistent asthma, and the geometric mean (interquartile range) of plasma FlOPs levels was 92.0 (79.5–104.7) RFU/mL (Table 1). In comparison to participants with remittent asthma, participants with persistent asthma had more often poor controlled asthma and an asthma symptom score > 2, reported more often the use of inhaled corticosteroids, and had higher plasma FlOPs levels (all P values≤0.02, Table 1). Plasma FlOPs levels increased with age (p-trend< 0.0001, Additional file 1: Table S2), were lower in never smokers than smokers (p = 0.02, Additional file 1: Table S2). No significant association was found between plasma FlOPs levels and other variables (Additional file 1: Table S2).

Table 1.

Description of participants with current asthma at baseline (EGEA2) according to change in current asthma between EGEA2 to EGEA3

All participants Participants with remittent asthma Participants with persistent asthma P-value
N 204 43 161
Age (years), mean ± SD 39.3 ± 16.9 36.7 ± 15.3 40.0 ± 17.3 0.26
Male, n (%) 99 (48.5) 16 (37.2) 83 (51.6) 0.09
Smoking status, n (%)
 Never-smoker 109 (53.4) 22 (51.2) 87 (54.0) 0.52
 Ex-smoker 46 (22.6) 8 (18.6) 38 (23.6)
 Current smoker 49 (24.0) 13 (30.2) 36 (22.4)
BMI (kg/m2), mean ± SD n = 203 23.4 ± 3.99 n = 160 0.40
23.8 ± 3.84 23.9 ± 3.81
Socioprofessional category, n (%)
 Unemployed 32 (15.7) 5 (11.6) 27 (16.8) 0.37
 Manager 64 (31.4) 12 (27.9) 52 (32.3)
 Technician 88 (43.1) 19 (44.2) 69 (42.8)
 Manual worker 20 (9.8) 7 (16.3) 13 (8.1)
Asthma onset years, mean ± SD N = 195 N = 39 N = 156 0.40
14.8 ± 14.7 16.6 ± 14.6 14.4 ± 14.7
Poor controlled asthmaa, n (%) N = 190 N = 38 N = 152 0.007
102 (53.7) 13 (34.2) 89 (58.6)
Use of inhaled corticosteroids, n (%) N = 200 N = 41 N = 159 0.009
132 (66.0) 20 (48.8) 112 (70.4)
Symptom score of asthmab, n (%) N = 199 N = 40 N = 159
 0 20 (10.0) 9 (22.5) 11 (6.9) 0.005
 1–2 30 (15.1) 8 (20.0) 22 (13.8)
 >2 149 (74.9) 23 (57.5) 126 (79.3)
Plasma FlOPs levels (RFU/mL), GM (q1-q3) 92.0 (79.5–104.7) 85.6 (76.0–96.5) 93.8 (79.9–104.8) 0.02
Residence time (years), mean ± SD 11.7 ± 10.2 (0–42) 10.3 ± 8.90 (0–31) 12.1 ± 10.5 (0–42) 0.31
Air pollutant levels and traffic metricsc, mean ± SD
 NO2 27.9 ± 13.9 29.7 ± 15.3 27.4 ± 13.5 0.34
 NOX 49.7 ± 32.7 53.2 ± 38.4 48.8 ± 31.0 0.44
 PM10 25.0 ± 4.07 25.1 ± 3.71 24.9 ± 4.18 0.88
 PM2.5 15.0 ± 2.04 15.5 ± 1.96 14.9 ± 2.05 0.20
 Traffic load 1,755,353 ± 4,718,630 1,672,062 ± 4,007,561 1,777,599 ± 4,902,148 0.90
 Traffic intensity 7307 ± 13,109 7027 ± 11,360 7382 ± 13,569 0.87
 O3 43.9 ± 4.62 43.1 ± 4.08 44.2 ± 4.74 0.15
 O3-summer 65.4 ± 6.20 64.7 ± 6.41 65.6 ± 6.14 0.38
Open in a new tab

SD standard deviation, BMI body mass index, FlOPs fluorescent oxidation products, GM geometric mean; q1-q3: 25th and 75th percentiles of the GM

aDefined according to GINA 2015 guidelines and from participants with partly controlled asthma or uncontrolled asthma (see Additional file 1)

bMore details in Additional file 1

cPollutant levels in μg/m3, traffic load in vehicles/day x meters, and traffic intensity in vehicles/day

Associations between outdoor air pollution, plasma FlOPs levels and persistent asthma

Among all pollutants studied, plasma FlOPs levels increased by 1 RFU/mL with PM10 and O3 exposures (adjusted (a)β = 0.04, 95% CI 0.001–0.08, p = 0.03 and aβ = 0.04, 95% CI 0.009–0.07, p = 0.02 for an increase of 10 μg/m3 of O3 and PM10, respectively, Table 2). The results were similar after excluding participants who lived at the same address for less than 1 year. The association between PM10 and plasma FlOPs levels did not remain significant with back-extrapolated data (aβ = 0.03, 95% CI -0.01–0.07, p = 0.22 for an increase of 10 μg/m3 of PM10, Table 2). The risk of persistent asthma decreased not significantly with exposure to NO2, NOx and PM2.5 (aOR ranging from 0.62 to 0.94), and increased not significantly with exposure to PM10, O3, O3-summer and road traffic, the greater effect being observed for O3 (aOR = 1.78, 95% CI 0.73–4.37, for an increase of 10 μg/m3 of O3, model 2, Additional file 1: Table S3). Results were similar after excluding participants who lived at the same address for less than 1 year (Table 2 and Additional file 1: Table S3). Further adjustment for season of plasma collection did not change the results with O3 (data not shown). The risk of persistent asthma increased with plasma FlOPs levels (unadjusted OR = 1.68, 95% CI 1.04–2.70, p = 0.03 for an increase of 1 interquartile range of FlOPs levels), and this association remained consistent after adjustment for age, sex and smoking status (aOR = 1.81, 95% CI 1.08–3.02, p = 0.02) for an increase of 1 interquartile range of FlOPs levels).

Table 2.

Associations between outdoor air pollution and plasma FlOPs levels

NO2 NOx PM10a PM2.5a Total traffic load on major roads in a 100-m buffer of the homeb Traffic intensity at the road nearest to a participant’s homeb O3 O3-sumer
Model 1

n

β crude

(95% CI)

P

204

0.007

(− 0.004,0.02)

0.19

204

0.006

(− 0.003,0.02)

0.15

146

0.04

(0.001,0.08)

0.04

146

0.03

(− 0.009,0.07)

0.15

204

0.008

(− 0.005,0.02)

0.24

204

0.0004

(− 0.005,0.006)

0.88

204

0.03

(− 0.004,0.06)

0.06

204

0.02

(− 0.03,0.07)

0.36
Model 2

n

β adjusted

(95% CI)

P

204

0.007

(− 0.003,0.02)

0.18

204

0.007

(− 0.002,0.02)

0.16

146

0.04

(0.001,0.08)

0.03

146

0.03

(− 0.008,0.07)

0.18

204

0.006

(− 0.006,0.02)

0.30

204

0.0002

(− 0.005,0.006)

0.94

204

0.04

(0.009,0.07)

0.02

204

0.02

(− 0.02,0.06)

0.45
Model 3

n

β adjusted

(95% CI)

P

204

0.007

(− 0.002,0.02)

0.14

204

0.006

(− 0.002,0.01)

0.12

72

0.03

(− 0.01,0.07)

0.22c
Model 4

n

β adjusted

(95% CI)

P

186

0.009

(− 0.003,0.02)

0.14

186

0.008

(− 0.002,0.02)

0.14

133

0.05

(0.006,0.09)

0.04

133

0.02

(− 0.02,0.06)

0.24

186

0.003

(− 0.01,0.02)

0.63

186

0.0005

(− 0.005,0.006)

0.86

186

0.05

(0.01,0.08)

0.01

186

0.02

(− 0.03,0.07)

0.37
Open in a new tab

The linear regression models were conducted with random effects on familial dependence and center. FlOPs levels were log10-transformed. NO2, nitrogen dioxide; NOx, nitrogen oxides; PM10, particulate matter with a diameter ≤ 10 μm; PM2.5, particulate matter with a diameter ≤ 5 μm. Results are expressed per 20 μg/m3 increase of NOx exposure, per 10 μg/m3 increase of NO2, PM10 O3 and O3-summer exposures, per 5 μg/m3 increase of PM2.5 exposure, per 4 million vehicles x meters per day increase of total traffic load, per 5000 vehicles per day increase of traffic intensity. Model 1: unadjusted. Model 2: adjusted for age, sex and smoking status. Model 3: with back-extrapolated pollution and adjusted for age, sex and smoking status. Model 4: after excluding the participants living at the same residential address <1 year

aNot back-extrapolated PM were only estimated in Paris and in Grenoble, and back extrapolated PM10 only in Paris

bEstimates were also adjusted for background NO2

cThe linear regression model was only conducted with random effects on familial dependence because back-extrapolated PM10 were estimated only in Paris

Ozone, FlOPs levels and persistent asthma: mediation analysis

Results were summarized in Table 3. We observed a positive total effect (ORTE = 2.16, 95% CI 0.70–11.9, P > 0.05), a positive natural direct effect of O3 on persistent asthma (ORCDE = 1.68, 95% CI 0.57–7.25, P > 0.05), and a positive natural indirect effect mediated by plasma FlOPs levels (ORNIE = 1.28, 95% CI 1.01–2.29, P = 0.04). Further decomposition of total effect showed that 50.3% of total effect was due to control direct effect, 8.6% due to the reference interaction, 26.5% due to mediated interaction and 14.6% due to the pure indirect effect. The percentage of total effect mediated by plasma FlOPs levels was 41.1% (26.5% + 14.6%). The percentage of total effect due to interaction was 35.1% (8.6% + 26.5%). These results were quite similar after excluding participants who lived at the same address for < 1 year (Additional file 1: Table S4). We also found that the controlled direct effect increased with plasma FlOPs levels (Additional file 1: Table S5).

Table 3.

Results of mediation analysis between O3, persistent asthma and plasma FlOPs levels using the CAUSALMED procedure (n = 204)

OR Estimate 95% CI
 Odds Ratio Total Effect 2.16 0.70–11.9
 Odds Ratio Natural Direct Effect 1.68 0.57–7.25
 Odds Ratio Natural Indirect Effect 1.28 1.01–2.29
Decomposition of the total effect
 Four-way Percent
 Controlled direct 50.3
 Reference interaction 8.6
 Mediated interaction 26.5
 Pure indirect 14.6
Open in a new tab

Models were adjusted for age, sex and smoking habits. The exposure was O3. The mediators were plasma FlOPs levels. The outcome was persistent asthma

Discussion

We studied and quantified the role of plasma FlOPs levels in the association between outdoor air pollution and persistent asthma. We found that plasma FlOPs levels increased with PM10 and O3 exposures, and the risk of persistent asthma increased with plasma FlOPs levels. We also found that the risk of persistent asthma increased with O3 exposure, but not significantly. We therefore performed mediation analysis to investigate the role of plasma FlOPs levels in the association between O3 exposure and persistent asthma. We found positive indirect effect mediated by plasma FIOPs levels accounting for 41% of the total effect, and O3 effect on persistent asthma increased with plasma FlOPs levels. Due to the limited sample size and borderline significant findings, and to the other biomarkers related to oxidative stress potentially involved in this association, the results need to be interpreted with caution.

To our knowledge, this study is the first one investigating the associations between outdoor air pollution and plasma FlOPs levels. FlOPs levels are biomarkers of damages related to oxidative stress reflecting a mixture of oxidation products from lipids, proteins and DNA [6]. These biomarkers are of growing interest in epidemiological studies because they are stable, easily measurable and applicable in large-scale human studies [9]. We found that plasma FlOPs levels increased with long-term exposure to O3, an irritant gas with a strong oxidative potential [5]. To date, no study has investigated the associations between O3 exposure and plasma FlOPs levels, and a recent review reported positive and significant associations between short-term exposure to O3 and 8-isoprostane, another biomarker related to oxidative stress [22]. We did not have data to properly assess by which extent acute exposure to O3 (over the past hours/days) could have biased our results. Nevertheless, the adjustment for the season of plasma collection did no change the results. As plasma FlOPs levels are biomarkers of damages that reflect cumulative oxidative stress, we hypothesized to find associations with long-term exposure to air pollution rather than with short-term air pollution. Further studies are needed to differentiate the effects of short-term and long-term exposure to air pollution, and in particular O3, on plasma FlOPs levels. We also found that plasma FlOPs levels increased with non-back extrapolated PM10. The way and the strength of the association with back-extrapolated PM10 were the same, but the association was not significant due to the small effective. Previously, we found that 8-isoprostane in exhaled breath condensate, a matrix close to the lungs, increased significantly with PM2.5 exposure in the EGEA study [23]. 8-isoprostane is a biomarker of damages related to oxidative stress, and a specific product of lipid peroxidation. In the present analysis, plasma FlOPs levels increased with PM2.5 exposure but the association was not significant. Fine and ultrafine particulates are known to be more harmful by penetrating deeper into the lungs and inducing damages due to oxidative stress both at the airways and systemic compartment [24]. The discrepancies in the results could be partly explained by difference in the sample sizes, in the composition and concentration of the particulates, and by difference in underlying mechanism related to the studied biomarker. In a previous work conducted among participants without asthma in the EGEA study, occupational exposure to irritant cleaning/disinfecting agents increased plasma FlOPs levels [13]. Overall, all these results underlined that occupational exposure to irritants, and outdoor air pollution exposure, especially exposure to O3 and PM10, were associated with higher plasma FlOPs levels, and outdoor air pollution increased oxidative stress at both lung and systemic level.

We studied persistent asthma in association with O3, PM and plasma FlOPs levels. Asthma is a chronic and heterogeneous disease defined by various overlapping phenotypes, including the phenotype “persistent asthma” [25]. Although persistent asthma is still under-studied in epidemiology, it reflects the activity and the evolution of asthma over time. Most associations between pollution and persistent asthma were close to 1; the risk of persistent asthma decreased with PM2.5 and increased with O3 and O3-summer exposures. The unexpected result observed for PM2.5 may be partly due to the lack of back-extrapolated data leading to an inverse temporality between PM2.5 and persistent asthma, or to random effect or residual bias. To date, only one study investigated the associations between exposure to outdoor air pollution and with persistent asthma in adults, and showed that living within 200 m of a major road was associated with persistent asthma in middle-aged Tasmanian participants [3]. Like us, the authors defined “current asthma” as “any episode of asthma or use of asthma medication during the last 12 months”. We also found that the risk of persistent asthma increased with plasma FlOPs levels. Our definition of “current asthma” included the report of asthma attack and the use of respiratory treatment in the last twelve months, and interestingly in adults of the EGEA study, asthma attacks, any asthma treatment and use of inhaled corticosteroids in the past 12 months were positively associated with plasma FlOPs levels [11]. Interestingly, leukocyte telomere length, which reflects oxidative-stress damages to DNA [26], was shorter in participants who had persistent asthma from childhood into adult as compared to those who had adolescent or adult-onset asthma [27]. From a larger sample size, it would be now interesting to study the associations between outdoor air pollution, plasma FlOPs levels and asthma incidence.

We acknowledge that performing a mediation analysis despite the non-significant association between O3 and persistent asthma may open a debate. We based our decision on the biological hypothesis that oxidative stress is one mechanism by which outdoor air pollution affects respiratory health. Although the association between O3 and persistent asthma was non-significant, the strength of the association between O3 and persistent asthma, and previous results obtained in the EGEA study guided our decision. Indeed, O3 was associated with severe asthma [18], uncontrolled asthma [28] and current asthma [23] in adults.

The CAUSALMED procedure is a recent tool available in SAS software to estimate causal mediation effects from observational data [19]. This procedure is advisable without prior knowledge about the lack of the interaction [29]. In mediation analysis, the random effects on center and familial dependence were not taken into in models, explaining the differences of results between the association between O3 and persistent asthma studied outside the mediation analysis and the direct effect. Beyond direct and indirect effects, the four-way decomposition shed insights into the role of both mediation and interaction in the associations between O3 and plasma FlOPs levels with persistent asthma. Overall, our mediation analysis may suggest a not negligible effect of O3 on persistent asthma through plasma FlOPs levels, and more precisely that effect of O3 on persistent asthma increased with plasma FlOPs levels. Due to the small sample size, the estimates from mediation analysis may be imprecise and the results should therefore be interpreted with caution. Further studies, with a larger study sample, using a model including other biomarkers related to oxidative stress or biomarkers related to other pathways, as well as the interrelations between these biomarkers, would be helpful to better understand the underlying biological mechanisms between outdoor air pollution and asthma.

Conclusion

For the first time in adults, we found that plasma FlOPs levels increased with O3 and PM10 exposures, and the risk of persistent asthma increased with plasma FlOPs levels. Overall, our results add insights into the potential role of plasma FlOPs levels in the association between O3 and persistent asthma, and add new evidence on the role of oxidative stress in the association between outdoor air pollution and asthma.

Supplementary information

12940_2019_532_MOESM1_ESM.doc (117KB, doc)

Additional file 1: Table S1. Description of participants included and not included in analyses. Table S2. Associations between plasma FlOPs levels and characteristics of participants. Table S3. Associations between outdoor air pollution and persistent asthma. Table S4. Results of mediation analysis using the CAUSALMED procedure among participants who lived at the same address for > 1 year (n = 186). Table S5. Controlled direct effect according to quantiles of plasma FlOPs levels (n = 204).

12940_2019_532_MOESM2_ESM.tif (84.9KB, tif)

Additional file 2: Figure S1. Flow chart of the studied population.

Acknowledgments

We thank Linda Valeri and Yiu-Fai Yung for their helpful suggestions.

EGEA cooperative group. Coordination: V Siroux (epidemiology, PI since 2013); F Demenais (genetics); I Pin (clinical aspects); R Nadif (biology); F Kauffmann (PI 1992-2012). Respiratory epidemiology: Inserm ex-U 700, Paris: M Korobaeff (Egea1), F Neukirch (Egea1); Inserm ex-U 707, Paris: I Annesi-Maesano (Egea1-2); Inserm ex-U 1018, Villejuif: F Kauffmann, MP Oryszczyn (Egea1-2); Inserm U 1168, Villejuif: N Le Moual, R Nadif, R Varraso; Inserm U 1209 Grenoble: V Siroux. Genetics: Inserm ex-U 393, Paris: J Feingold; Inserm U 946, Paris: E Bouzigon, F Demenais, MH Dizier; CNG, Evry: I Gut (now CNAG, Barcelona, Spain), M Lathrop (now Univ McGill, Montreal, Canada). Clinical centers: Grenoble: I Pin, C Pison; Lyon: D Ecochard (Egea1), F Gormand, Y Pacheco; Marseille: D Charpin (Egea1), D Vervloet (Egea1-2); Montpellier: J Bousquet; Paris Cochin: A Lockhart (Egea1), R Matran (now in Lille); Paris Necker: E Paty (Egea1-2), P Scheinmann (Egea1-2); Paris-Trousseau: A Grimfeld (Egea1-2), J Just. Data and quality management: Inserm ex-U155 (Egea1): J Hochez; Inserm U 1168, Villejuif: N Le Moual; Inserm ex-U780: C Ravault (Egea1-2); Inserm ex-U794: N Chateigner (Egea1-2); Grenoble: J Quentin (Egea1-2).

The authors thank all those who participated to the setting of the study and on the various aspects of the examinations involved: interviewers, technicians for lung function testing and skin prick tests, blood sampling, IgE determinations, coders, those involved in quality control, data and sample management and all those who supervised the study in all centers. The authors are grateful to the three CIC-Inserm of Necker, Grenoble and Marseille who supported the study and in which participants were examined. They are also grateful to the biobanks in Lille (CIC-Inserm), and at Annemasse (Etablissement français du sang) where biological samples are stored. They are indebted to all the individuals who participated, without whom the study would not have been possible. The authors thank N. Jeannée from Géovariances and all those from the French Institute for Environment, and particularly M. Ba, for their work on the geo-spatial models.

We acknowledged the European Respiratory Society international congress and the International Society of Exposure Science and the International Society for Environmental Epidemiology joint annual meeting for giving us the opportunity to present a part of these works and publishing them as conference abstracts.

Abbreviations

CI

confidence interval

EGEA

Epidemiological study of the Genetic and Environmental factors of Asthma

ESCAPE

European Study of Cohorts for Air Pollution Effects

FlOPs

fluorescent oxidation products

IFEN

French Institute of Environment

NO2

nitrogen dioxide

NOx

nitrogen oxides

O3

ozone

O3-sumer

summer ozone

OR

odds ratio

PM10

particulate matter with a diameter ≤ 10 μm

PM2.5

particulate matter with a diameter ≤ 2.5 μm

Authors’ contributions

AH, RM and RN designed and conducted the research; MS, VS, NLM, BB, NK and BJ: provided essential reagents or provided essential materials; FZ performed biological analyses; AH, ZL, RV and RN: analyzed data or performed statistical analysis; AH, RM and RN: wrote the manuscript and had primary responsibility for final content; all authors read, edited and approved the final manuscript.

Funding

This work was supported by the National Hospital program of clinical research [PHRC-national 2012, EvAdA]; ANR-CES-2009; Region Nord Pas-de-Calais; Merck Sharp & Dohme (MSD); the GA2LEN (Global Allergy and Asthma European Network) project; the Fonds AGIR pour les maladies chroniques and ESCAPE [FP7/2007–2011, Grant Nr.211250].

AH is financed by the university hospital center of Lille.

Availability of data and materials

Due to third party restrictions, EGEA data are not publicly available. Please see the following URL for more information:

https://egeanet.vjf.inserm.fr/index.php/en/contacts-en. Interested researchers should contact egea. cohorte@inserm.fr with further questions regarding data access.

Ethics approval and consent to participate

Ethical approval was obtained from the relevant institutional review board committees (Cochin Port-Royal Hospital and Necker-Enfants Malades Hospital, Paris).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Régis Matran and Rachel Nadif contributed equally to this work.

Contributor Information

Anaïs Havet, Email: anais.havet@gmail.com.

Zhen Li, Email: lizhenscu@163.com.

Farid Zerimech, Email: farid.zerimech@chru-lille.fr.

Margaux Sanchez, Email: margaux.sanchez@anses.fr.

Valérie Siroux, Email: valerie.siroux@univ-grenoble-alpes.fr.

Nicole Le Moual, Email: nicole.lemoual@inserm.fr.

Bert Brunekreef, Email: b.brunekreef@uu.nl.

Nino Künzli, Email: nino.kuenzli@unibas.ch.

Bénédicte Jacquemin, Email: benedicte.jacquemin@inserm.fr.

Raphaëlle Varraso, Email: raphaelle.varraso@inserm.fr.

Régis Matran, Email: regis.matran@univ-lille.fr.

Rachel Nadif, Email: rachel.nadif@inserm.fr.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s12940-019-0532-0.

References

  • 1.Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet. 2015;383(9928):1581–1592. doi: 10.1016/S0140-6736(14)60617-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kar Kurt O, Zhang J, Pinkerton KE. Pulmonary health effects of air pollution. Curr Opin Pulm Med. 2016;22(2):138–143. doi: 10.1097/MCP.0000000000000248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bowatte G, Lodge CJ, Knibbs LD, Erbas B, Perret JL, Jalaludin B, et al. Traffic related air pollution and development and persistence of asthma and low lung function. Environ Int. 2018;113:170–176. doi: 10.1016/j.envint.2018.01.028. [DOI] [PubMed] [Google Scholar]
  • 4.Kleniewska P, Pawliczak R. The participation of oxidative stress in the pathogenesis of bronchial asthma. Biomed Pharmacother. 2017;94:100–108. doi: 10.1016/j.biopha.2017.07.066. [DOI] [PubMed] [Google Scholar]
  • 5.Lodovici M, Bigagli E. Oxidative stress and air pollution exposure. J Toxicol. 2011;2011:487074. doi: 10.1155/2011/487074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Margaritelis NV, Cobley JN, Paschalis V, Veskoukis AS, Theodorou AA, Kyparos A, Nikolaidis MG. Going retro: oxidative stress biomarkers in modern redox biology. Free Radic Biol Med. 2016;98:2–12. doi: 10.1016/j.freeradbiomed.2016.02.005. [DOI] [PubMed] [Google Scholar]
  • 7.Guerra S. New asthma biomarkers: shorter telomeres, longer disease? Am J Respir Crit Care Med. 2014;190(4):356–358. doi: 10.1164/rccm.201407-1248ED. [DOI] [PubMed] [Google Scholar]
  • 8.Wu T, Willett WC, Rifai N, Rimm EB. Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. Am J Epidemiol. 2007;166(5):552–560. doi: 10.1093/aje/kwm119. [DOI] [PubMed] [Google Scholar]
  • 9.Wu T, Rifai N, Willett WC, Rimm EB. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. Am J Epidemiol. 2007;166(5):544–551. doi: 10.1093/aje/kwm120. [DOI] [PubMed] [Google Scholar]
  • 10.Jensen MK, Wang Y, Rimm EB, Townsend MK, Willett W, Wu T. Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women J. Am Heart Assoc. 2013;2(5):e000195. doi: 10.1161/JAHA.113.000195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Andrianjafimasy M, Zerimech F, Akiki Z, Huyvaert H, Le Moual N, Siroux V, et al. Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study. Eur Respir J. 2017;50(6):1701193. doi: 10.1183/13993003.01193-2017. [DOI] [PubMed] [Google Scholar]
  • 12.Hart JE, Wu T, Laden F, Garshick E. Plasma fluorescent oxidation products and short-term occupational particulate exposures. Am J Ind Med. 2012;55(10):953–960. doi: 10.1002/ajim.22073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dumas O, Matran R, Zerimech F, Decoster B, Huyvaert H, Ahmed I, et al. Occupational exposures and fluorescent oxidation products in 723 adults of the EGEA study. Eur Respir J. 2015;46(1):258–261. doi: 10.1183/09031936.00177614. [DOI] [PubMed] [Google Scholar]
  • 14.Kauffmann F, Dizier MH, Annesi-Maesano I, Bousquet J, Charpin D, Demenais F, et al. EGEA (epidemiological study on the genetics and environment of asthma, bronchial hyperresponsiveness and atopy) – descriptive characteristics. Clin Exp Allergy. 1999;29(Suppl 4):17–21. [PubMed] [Google Scholar]
  • 15.Kauffmann F, Dizier MH. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)--design issues. EGEA Co-operative Group. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 1995;25 Suppl 2:19–22. [DOI] [PubMed]
  • 16.Bouzigon E, Nadif R, Le Moual N, Dizier MH, Aschard H, Boudier A, et al. Facteurs génétiques et environnementaux de l’asthme et de l’allergie : synthèse des résultats de l’étude EGEA. Rev Mal Respir. 2015;32(8):822–840. doi: 10.1016/j.rmr.2014.12.005. [DOI] [PubMed] [Google Scholar]
  • 17.Nadif R, Bouzigon E, Le Moual N, Siroux V. EGEA collection: a biobank devoted to asthma and asthma-related phenotypes. Open J Bioresources. 2017;4(1):5. doi: 10.5334/ojb.24. [DOI] [Google Scholar]
  • 18.Rage E, Siroux V, Künzli N, Pin I, Kauffmann F. Air pollution and asthma severity in adults. Occup Environ Med. 2009;66(3):182–188. doi: 10.1136/oem.2007.038349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.SAS/STAT® 14.3 User’s Guide The CAUSALMED Procedure. https://support.sas.com/documentation/onlinedoc/stat/143/causalmed.pdf. .
  • 20.Valeri L, Vanderweele TJ. Mediation Analysis Allowing for Exposure – Mediator Interactions and Causal Interpretation: Theoretical Assumptions and Implementation With SAS and SPSS Macros. Psychol Methods 2013;18(2):137–150. 2. [DOI] [PMC free article] [PubMed]
  • 21.VanderWeele TJ. A unification of mediation and interaction: a four-way decomposition. Epidemiology. 2014;25(5):749–761. doi: 10.1097/EDE.0000000000000121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bromberg PA. Mechanisms of the acute effects of inhaled ozone in humans. Biochim Biophys Acta. 2016;1860(12):2771–2781. doi: 10.1016/j.bbagen.2016.07.015. [DOI] [PubMed] [Google Scholar]
  • 23.Havet A, Zerimech F, Sanchez M, Siroux V, Le Moual N, Brunekreef B, et al. Outdoor air pollution , exhaled 8-isoprostane and current asthma in adults : the EGEA study. Eur Respir J. 2018;51(4):1702036. doi: 10.1183/13993003.02036-2017. [DOI] [PubMed] [Google Scholar]
  • 24.Valavanidis A, Fiotakis K, Vlachogianni T. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. Journal of Environmental Science and Health Part C. 2008;26(4):339–362. doi: 10.1080/10590500802494538. [DOI] [PubMed] [Google Scholar]
  • 25.Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: is prevention possible? Lancet. 2015;386(9998):1075–1085. doi: 10.1016/S0140-6736(15)00156-7. [DOI] [PubMed] [Google Scholar]
  • 26.Clemente DBP, Vrijheid M, Martens DS, Bustamante M, Chatzi L, Danileviciute A, et al. Prenatal and childhood traffic-related air pollution exposure and telomere length in European children: the HELIX project. Environ Health Perspect. 2019;127(8):87001. doi: 10.1289/EHP4148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Belsky DW, Shalev I, Sears MR, Hancox RJ, Lee Harrington H, Houts R, et al. Is chronic asthma associated with shorter leukocyte telomere length at midlife? Am J Respir Crit Care Med. 2014;190(4):384–339. doi: 10.1164/rccm.201402-0370OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Jacquemin B, Kauffmann F, Pin I, Le Moual N, Bousquet J, Gormand F, et al. Air pollution and asthma control in the epidemiological study on the genetics and environment of asthma. J Epidemiol Community Health. 2012;66(9):796–802. doi: 10.1136/jech.2010.130229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yung YF, Lamm M and Zhang W. Causal mediation analysis with the CAUSALMED procedure https://www.sas.com/content/dam/SAS/support/en/sas-global-forum-proceedings/2018/1991-2018.pdf. .

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

12940_2019_532_MOESM1_ESM.doc (117KB, doc)

Additional file 1: Table S1. Description of participants included and not included in analyses. Table S2. Associations between plasma FlOPs levels and characteristics of participants. Table S3. Associations between outdoor air pollution and persistent asthma. Table S4. Results of mediation analysis using the CAUSALMED procedure among participants who lived at the same address for > 1 year (n = 186). Table S5. Controlled direct effect according to quantiles of plasma FlOPs levels (n = 204).

12940_2019_532_MOESM2_ESM.tif (84.9KB, tif)

Additional file 2: Figure S1. Flow chart of the studied population.

Data Availability Statement

Due to third party restrictions, EGEA data are not publicly available. Please see the following URL for more information:

https://egeanet.vjf.inserm.fr/index.php/en/contacts-en. Interested researchers should contact egea. cohorte@inserm.fr with further questions regarding data access.

Articles from Environmental Health are provided here courtesy of BMC

RESOURCES